The Option. (a) Issuer hereby grants to Grantee an unconditional, irrevocable option (the "Option") to purchase, subject to the terms hereof, up to 13,266,587 fully paid and nonassessable shares of common stock, having a par value of one dollar per share ("Common Stock"), of Issuer at a price per share in cash equal to $65.00 (the "Option Price"); provided, however, that in no event shall the number of shares for which the Option is exercisable exceed 19.9% of the shares of Common Stock issued and out standing at the time of exercise (without giving effect to the shares of Common Stock issued or issuable under the Option) (the "Maximum Applicable Percentage"). The number of shares of Common Stock purchasable upon exercise of the Option and the Option Price are subject to adjustment as set forth herein.
The Option. Grant Recipient(s) hereby grant to the Project Stakeholder(s) that contribute(s) at least ten percent (10%) of the Project budget an Option to acquire an exclusive or non-exclusive right to exploit Results in the respective Project Stakeholder’s Field of Use or acquire ownership of those Results. A Project Stakeholder may exercise the Option for any specific part of the Results by written notification to the respective Grant Recipient within three (3) months of being informed of the Results. Upon exercising the Option, Parties concerned shall promptly enter negotiations in good faith to reach agreement on fair and reasonable conditions within six (6) months of the written exercise of the Option. The licence or transfer agreement shall include at least the following provisions: The respective Project Stakeholder obtains the right to use and exploit the Results in its Field of Use; The respective Project Stakeholder pays to the Grant Recipient(s) that own the Results a fair and reasonable market price. Contributions by Project Stakeholders of at least thirty percent (30%) of the Project budget are considered a reasonable market price in exchange for a non-exclusive licence in the Field of Use of the respective Project Stakeholder; The respective Project Stakeholder shall make best endeavours to exploit the Results in its Field of Use and report to the Grant Recipient(s) on the progress of the exploitation frequently; Grant Recipients shall retain the right at all times to use Results for further non-commercial research and education on a royalty-free basis; Grant Recipient(s) shall not be held liable for any loss or damage incurred by the respective Project Stakeholder arising out of the use or exploitation of Results. The respective Project Stakeholder shall indemnify Grant Recipient(s) against claims from third parties arising out of the use or exploitation of Results by or through the respective Project Stakeholder. The licence or transfer agreement shall take into account the Ten Principles for Socially Responsible Licensing as laid down in the NFU report on ‘Ten Principles for Socially Responsible Licensing’. In the event that a Project Stakeholder has failed to exercise the Option within the set timeframe the Option for the Results concerned shall lapse and the respective Grant Recipient(s) shall be free to offer the Results concerned to a third party.
The Option. The Company hereby grants to NuVen the option to acquire Five Hundred Thousand (500,000) shares of the Company's Common Stock (the "Option"), subject to adjustment as set forth herein (such shares, as adjusted, are hereinafter referred to as the "Option Shares"), at a purchase price of Fifty Cents ($.50) per share ("Option Price").
The Option. Under and subject to the provisions of the Corporation's Employee Stock Option Plan as amended and as in effect from time to time ("Plan"), the Corporation hereby grants to Employee a non-statutory option to purchase an aggregate of 461,539 shares of Common Stock of the Corporation at the price of U.S. $1.30 per share ("Option"), subject to the following conditions:
The Option. The Company hereby grants to the Optionee an option (the “Option”) to purchase all or any part of an aggregate of such number of shares of Common Stock as is set forth on the signature page hereto (subject to adjustment as provided in Section 9 of the Interline Brands, Inc. 2012 Stock Option Plan (the “Plan”) on the terms and conditions set forth in this Agreement and as otherwise provided in the Plan. This Option is not intended to be treated as an “incentive stock option,” as such term is defined in Section 422 of the Internal Revenue Code of 1986, as amended.
The Option. Subject to the terms and conditions hereof, the Optionee is hereby granted the Option, at any time or from time to time commencing on the date of Option Agreement and at or before 5:00 P.M., Eastern Time, on or before thirty (30) days following the Conversion Date, as defined in the Loan Agreement (as defined in the Purchase Agreement) (such period hereinafter the "Option Exercise Period"), but not thereafter, to subscribe for and purchase the Option Shares for a purchase price of One Million Two Hundred Fifty Thousand Dollars ($1,250,000). (the "Option Exercise Price"). If the rights represented hereby shall not be exercised during the Option Exercise Period, this Option shall become and be void without further force or effect, and all rights represented hereby shall cease and expire. V.
The Option. The Company grants the Option Holder the following options for purchasing or subscribing to shares in the Company (the “Options”): Date of grant: [=date of grant] Number granted: [=number of shares] shares (the “Option Shares”) Exercise price per share: NOK [=strike price] (the “Strike Price”) Date of expiration: 10 years after the date of grant
The Option. The Option gives you the right to buy a certain number of shares of Cigna Common Stock (Shares) during the Option Period (described in paragraph 2) at the Option Price. Your Option Grant Agreement lists the number of Shares and your Option Price. To buy the Shares at the Option Price, you must exercise the Option.
The Option. Nothing in this Option Agreement shall confer upon the Optionee any right to continue as a director of the Company or any Parent or Subsidiary.
The Option. The Company hereby grants to Optionee the option to acquire One Million (1,000,000) shares of the Company's Common Stock (the "Option Shares"), at a purchase price as follows: Two Hundred Fifty Thousand (250,000) shares exercisable at $.05 per share, Two Hundred Fifty Thousand (250,000) shares exercisable at $.15 per share, Two Hundred Fifty Thousand (250,000) shares exercisable at $.30 per share, Two Hundred Fifty Thousand (250,000) shares exercisable at $.45 per share.